Professor Sarah Parish
BSc, MSc, DPhil
Professor of Medical Statistics and Epidemiology
- MRC Programme Leader
Sarah Parish studied Mathematics at Bristol and Oxford Universities and joined the unit which became CTSU (and is now part of NDPH) in 1978. She has played a major role as a statistician in the establishment, conduct and interpretation of CTSU’s series of ground-breaking large-scale randomised trials in the treatment and prevention of cardiovascular disease. She has also been active in developing large-scale blood-based observational studies with extensive biomarker panels and genotyping. As the Director of Statistics in Vascular Trials and Genetic Epidemiology, she now leads statistical teams engaged in a spectrum of complimentary research. Her particular interests include: identifying genetic risk factors for the side-effects of common cardiovascular treatments; investigating causality in relation to factors such as adiposity and dementia that are responsible for major burdens of disease, using the large UK and China Kadoorie biobanks.
A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions.
Chan MS. et al, (2021), J Gerontol A Biol Sci Med Sci
Height and risk of ischaemic stroke subtypes: a Mendelian randomisation study
Linden A. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2415 - 2415
Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial
Rocca B. et al, (2020), EUROPEAN HEART JOURNAL, 41, 2926 - 2926
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom.
Hopewell JC. et al, (2020), Eur Heart J, 41, 3336 - 3342
Approaches to minimising the epidemiological impact of sources of systematic and random variation that may affect biochemistry assay data in UK Biobank.
Allen NE. et al, (2020), Wellcome Open Res, 5